{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:18:06Z","timestamp":1788315486709,"version":"build-2803163510"},"reference-count":50,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"unspecified","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2023ZD0508200"],"award-info":[{"award-number":["2023ZD0508200"]}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2023ZD0508203"],"award-info":[{"award-number":["2023ZD0508203"]}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2023ZD0508204"],"award-info":[{"award-number":["2023ZD0508204"]}]},{"name":"Science and Technology Projects in Guangzhou","award":["2023A04J1087"],"award-info":[{"award-number":["2023A04J1087"]}]},{"name":"Medical Science and Technology Research Foundation of Guangdong Province","award":["A2022309"],"award-info":[{"award-number":["A2022309"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,12,24]]},"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n<jats:title>Objective<\/jats:title>\n<jats:p>As an emerging technology, Android-based open-source closed-loop system also called Android Artificial Pancreas System (AAPS), has been increasingly validated by evidence for its effectiveness in improving glycaemic outcomes, positioning it as a crucial option for managing type 1 diabetes (T1D). However, there are still only a few studies examining the experiences of using AAPS, and relevant qualitative studies have not been conducted in Asia so far. This study aimed to explore the experiences and opinions of adult patients with T1D on the AAPS.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Design<\/jats:title>\n<jats:p>Semi-structured interviews and the Insulin Dosing Systems: Perceptions, Ideas, Reflections and Expectations questionnaires were conducted among patients. The questionnaire was scored on a 100-point scale. Thematic analysis was adopted to analyse the transcribed text. Recruitment of interviewees would be halted when no new themes emerged. The scores of the questionnaire on AAPS satisfaction were calculated, and the Mann-Whitney U test was used to compare the results of different sections of the questionnaire.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Setting<\/jats:title>\n<jats:p>Guangdong Province in China.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Participants<\/jats:title>\n<jats:p>This study recruited patients with T1D from the Guangdong T1D translational medicine study and the \u2018Tang Tang Quan\u2019 T1D online community in China, who participated in a clinical trial on the efficacy and safety of AAPS.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The study interviewed 20 adults with T1D aged 32\u00b19.94 years. The T1D duration was 10.93\u00b16.26 years and the glycated haemoglobin was 7.38\u00b10.53%. Five main themes were identified: (1) expectations and feedback on AAPS; (2) impact on quality of life; (3) impact on blood glucose management; (4) user experiences; (5) suggestions for AAPS. The average score of AAPS satisfaction was 73.69 (65.94, 85.94). Mann-Whitney U test suggested that the satisfaction derived from glucose management with AAPS surpassed the satisfaction attributed to the enhancement of their overall quality of life (p&lt;0.05).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Adults with T1D had generally positive experiences with AAPS. The future focus of AAPS research and development should be on optimising glycaemic management, improving device experience and reducing costs.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Trial registration number<\/jats:title>\n<jats:p>\n    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05726461\">NCT05726461<\/jats:ext-link>; Pre-results\n.\n<\/jats:p>\n<\/jats:sec>","DOI":"10.1136\/bmjopen-2024-094333","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T16:07:46Z","timestamp":1737043666000},"page":"e094333","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Experiences and opinions of adults with type 1 diabetes on the android-based open-source closed-loop system in China: a qualitative study"],"prefix":"10.1136","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct05726461","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05726461","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3095-2444","authenticated-orcid":false,"given":"Qingying","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyun","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7062-0147","authenticated-orcid":false,"given":"Jinhua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daizhi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaofan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"2025031814173159000_15.1.e094333.1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(22)00218-2"},{"key":"2025031814173159000_15.1.e094333.2","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-1140"},{"key":"2025031814173159000_15.1.e094333.3","first-page":"976","article-title":"Life Expectancy and Lifetime Health Care Expenditures for Type 1 Diabetes: A Nationwide Longitudinal Cohort of Incident Cases Followed for 14 Years","volume":"19","author":"Ou","year":"2016","journal-title":"V H"},{"key":"2025031814173159000_15.1.e094333.4","doi-asserted-by":"publisher","DOI":"10.2337\/db11-1625"},{"key":"2025031814173159000_15.1.e094333.5","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-0078"},{"key":"2025031814173159000_15.1.e094333.6","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-016-0670-y","article-title":"Empowered citizen \u201chealth hackers\u201d who are not waiting","volume":"14","author":"Omer","year":"2016","journal-title":"BMC Med"},{"key":"2025031814173159000_15.1.e094333.7","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s13300-019-00679-y","article-title":"Do-It-Yourself Artificial Pancreas Systems in Type 1 Diabetes: Perspectives of Two Adult Users, a Caregiver and Three Physicians","volume":"10","author":"Marshall","year":"2019","journal-title":"Diabetes Ther"},{"key":"2025031814173159000_15.1.e094333.8","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s13300-020-00823-z","article-title":"The Do-It-Yourself Artificial Pancreas: A Comprehensive Review","volume":"11","author":"Kesavadev","year":"2020","journal-title":"Diabetes Ther"},{"key":"2025031814173159000_15.1.e094333.9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S2213-8587(21)00267-9","article-title":"Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals","volume":"10","author":"Braune","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025031814173159000_15.1.e094333.10","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-020-01623-4"},{"key":"2025031814173159000_15.1.e094333.11","unstructured":"Androidaps . Welcome to the androidaps documentation. Available: https:\/\/androidaps.readthedocs.io\/en\/latest\/ [Accessed 13 Nov 2023]."},{"key":"2025031814173159000_15.1.e094333.12","doi-asserted-by":"crossref","DOI":"10.1177\/2042018820950146","article-title":"Use of a do-it-yourself artificial pancreas system is associated with better glucose management and higher quality of life among adults with type 1 diabetes","volume":"11","author":"Wu","year":"2020","journal-title":"Ther Adv Endocrinol Metab"},{"key":"2025031814173159000_15.1.e094333.13","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1111\/ced.15381","article-title":"A novice\u2019s guide to qualitative health professions education research","volume":"47","author":"Finn","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"2025031814173159000_15.1.e094333.14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1037\/a0040383","article-title":"Psychology, technology, and diabetes management","volume":"71","author":"Gonder-Frederick","year":"2016","journal-title":"Am Psychol"},{"key":"2025031814173159000_15.1.e094333.15","doi-asserted-by":"publisher","DOI":"10.1177\/193229681100500610"},{"key":"2025031814173159000_15.1.e094333.16","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1177\/1932296818800065","article-title":"Women\u2019s Experiences of Day-and-Night Closed-Loop Insulin Delivery During Type 1 Diabetes Pregnancy","volume":"12","author":"Farrington","year":"2018","journal-title":"J Diabetes Sci Technol"},{"key":"2025031814173159000_15.1.e094333.17","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15020","article-title":"Lived experience of older adults with type 1 diabetes using closed-loop automated insulin delivery in a randomised trial","volume":"40","author":"Kubilay","year":"2023","journal-title":"Diabet Med"},{"key":"2025031814173159000_15.1.e094333.18","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14708","article-title":"\u201cWe\u2019re all on the same team\u201d. Perspectives on the future of artificial pancreas systems by adults in Australia with type 1 diabetes using open-source technologies: A qualitative study","volume":"39","author":"Schipp","year":"2022","journal-title":"Diabet Med"},{"key":"2025031814173159000_15.1.e094333.19","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1089\/dia.2020.0652","article-title":"How Adults with Type 1 Diabetes Are Navigating the Challenges of Open-Source Artificial Pancreas Systems: A Qualitative Study","volume":"23","author":"Schipp","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"2025031814173159000_15.1.e094333.20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271096","article-title":"A scoping review of Do-It-Yourself Automated Insulin Delivery system (DIY AID) use in people with type 1 diabetes","volume":"17","author":"Morrison","year":"2022","journal-title":"PLoS One"},{"key":"2025031814173159000_15.1.e094333.21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-073263","article-title":"Efficacy and safety of Android artificial pancreas system use at home among adults with type 1 diabetes mellitus in China: protocol of a 26-week, free-living, randomised, open-label, two-arm, two-phase, crossover trial","volume":"13","author":"Lei","year":"2023","journal-title":"BMJ Open"},{"key":"2025031814173159000_15.1.e094333.22","doi-asserted-by":"publisher","DOI":"10.1080\/08870440903194015"},{"key":"2025031814173159000_15.1.e094333.23","unstructured":"Barnard-Kelly K . INSPIRE questionnaire. 2024. Available: https:\/\/diabeteswise.org\/en\/resources\/getting-treatment\/scales-and-measures [Accessed 13 Nov 2024]."},{"key":"2025031814173159000_15.1.e094333.24","unstructured":"Barnard-Kelly K . The INSPIRE questionnaire for users with type 1 diabetes. 2024. Available: https:\/\/www.wjx.cn\/vm\/QtOz24F.aspx [Accessed 27 Aug 2024]."},{"key":"2025031814173159000_15.1.e094333.25","doi-asserted-by":"publisher","DOI":"10.1191\/1478088706qp063oa"},{"key":"2025031814173159000_15.1.e094333.26","doi-asserted-by":"publisher","DOI":"10.1097\/01.NNR.0000313482.33917.7d"},{"key":"2025031814173159000_15.1.e094333.27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2203913"},{"key":"2025031814173159000_15.1.e094333.28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jcjd.2023.09.003","article-title":"Open-source Artificial Pancreas Systems Are Safe and Effective When Supported In-clinic: Outcomes in 248 Consecutive Type 1 Diabetes Clients","volume":"48","author":"Samuel","year":"2024","journal-title":"Can J Diabetes"},{"key":"2025031814173159000_15.1.e094333.29","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1177\/1932296820955168","article-title":"Training and Support for Hybrid Closed-Loop Therapy","volume":"16","author":"Boughton","year":"2022","journal-title":"J Diabetes Sci Technol"},{"key":"2025031814173159000_15.1.e094333.30","doi-asserted-by":"publisher","DOI":"10.1177\/0145721717697244"},{"key":"2025031814173159000_15.1.e094333.31","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-0400"},{"key":"2025031814173159000_15.1.e094333.32","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2014.0316"},{"key":"2025031814173159000_15.1.e094333.33","doi-asserted-by":"crossref","first-page":"109784","DOI":"10.1016\/j.diabres.2022.109784","article-title":"Switching from predictive low glucose suspend to advanced hybrid closed loop control: Effects on glucose control and patient reported outcomes","volume":"185","author":"Boscari","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"2025031814173159000_15.1.e094333.34","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2014-000025","article-title":"Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents","volume":"2","author":"Barnard","year":"2014","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2025031814173159000_15.1.e094333.35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ecl.2019.10.004","article-title":"Psychosocial Aspects of Diabetes Technology Use: The Child and Family Perspective","volume":"49","author":"Papadakis","year":"2020","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2025031814173159000_15.1.e094333.36","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1089\/dia.2021.0485","article-title":"Qualitative Study of User Experiences with Loop, an Open-Source Automated Insulin Delivery System","volume":"24","author":"Suttiratana","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"2025031814173159000_15.1.e094333.37","unstructured":"Libre F . FreeStyle libre 3 system. 2024. Available: https:\/\/www.freestyle.abbott\/uk-en\/products\/freestyle-libre-3.html [Accessed 27 Aug 2024]."},{"key":"2025031814173159000_15.1.e094333.38","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1089\/dia.2022.0011","article-title":"Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes","volume":"24","author":"Garg","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"2025031814173159000_15.1.e094333.39","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/1932296816682762","article-title":"Moving Toward a Unified Platform for Insulin Delivery and Sensing of Inputs Relevant to an Artificial Pancreas","volume":"11","author":"Graf","year":"2017","journal-title":"J Diabetes Sci Technol"},{"key":"2025031814173159000_15.1.e094333.40","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1089\/dia.2021.0540","article-title":"Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal Trial","volume":"24","author":"Brazg","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"2025031814173159000_15.1.e094333.41","doi-asserted-by":"publisher","DOI":"10.2337\/cd20-0026"},{"key":"2025031814173159000_15.1.e094333.42","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1089\/dia.2019.0368","article-title":"Cost of Treating Skin Problems in Patients with Diabetes Who Use Insulin Pumps and\/or Glucose Sensors","volume":"22","author":"Berg","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"2025031814173159000_15.1.e094333.43","doi-asserted-by":"crossref","DOI":"10.2196\/14087","article-title":"Real-World Use of Do-It-Yourself Artificial Pancreas Systems in Children and Adolescents With Type 1 Diabetes: Online Survey and Analysis of Self-Reported Clinical Outcomes","volume":"7","author":"Braune","year":"2019","journal-title":"JMIR Mhealth Uhealth"},{"key":"2025031814173159000_15.1.e094333.44","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1177\/1932296819883876","article-title":"Peer Mentoring in the Do-it-Yourself Artificial Pancreas System Community","volume":"14","author":"Crocket","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"2025031814173159000_15.1.e094333.45","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/jdi.13870","article-title":"High engagement in mobile peer support is associated with better glycemic control in type\u20091 diabetes: A real-world study","volume":"13","author":"Liu","year":"2022","journal-title":"J Diabetes Investig"},{"key":"2025031814173159000_15.1.e094333.46","doi-asserted-by":"publisher","DOI":"10.1177\/1932296819894296"},{"key":"2025031814173159000_15.1.e094333.47","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14575","article-title":"Cost considerations for adoption of diabetes technology are pervasive: A qualitative study of persons living with type 1 diabetes and their families","volume":"38","author":"Addala","year":"2021","journal-title":"Diabet Med"},{"key":"2025031814173159000_15.1.e094333.48","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/pdi.2216","article-title":"DIY artificial pancreas systems: here to stay?","volume":"36","author":"Crabtree","year":"2019","journal-title":"Pract Diab"},{"key":"2025031814173159000_15.1.e094333.49","unstructured":"NDSS . Eligibility expansion for all people with type 1 diabetes to access subsidised CGM and flash GM products through the NDSS. 2022. Available: https:\/\/www.ndss.com.au\/news\/eligibility-expansion-for-all-people-with-type-1-diabetes-to-access-subsidised-cgm-and-flash-gm-products-through-the-ndss\/ [Accessed 27 Aug 2024]."},{"key":"2025031814173159000_15.1.e094333.50","doi-asserted-by":"crossref","first-page":"473","DOI":"10.5694\/mja2.51118","article-title":"Utilisation, access and recommendations regarding technologies for people living with type 1 diabetes: consensus statement of the ADS\/ADEA\/APEG\/ADIPS Working Group","volume":"215","author":"Pease","year":"2021","journal-title":"Med J Aust"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-094333","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:12:04Z","timestamp":1742429524000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-094333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,15]]},"published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1136\/bmjopen-2024-094333"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-094333","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}